Search

Search Constraints

You searched for: Author/Creator Cid, Maria C

Search Results

1. 185. GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE. (29th March 2019)

2. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Issue 4 (2nd March 2012)

3. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Issue 1 (3rd July 2019)

4. 272 Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the GiACTA trial. (12th April 2019)

6. Authors' response to the eLetter by Moiseev et al. Issue 11 (8th August 2014)

8. Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis. Issue 4 (19th January 2022)

9. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis. Issue 6 (23rd December 2015)

10. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. (23rd January 2020)